Nolato ABCHIX:NOLABS 78 PB Ratio is 2.25 as of Jul. 11, 2026, which is 43% below its 10-year median of 3.92. GuruFocus rates CHIX:NOLABS with a GF Score™ of 78/100 and a GF Value™ of kr58.57 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Nolato AB ranks worse than 52.8% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-11), Nolato AB's share price is kr48.875. Nolato AB's Book Value per Share for the quarter that ended in Mar. 2026 was kr21.71. Hence, Nolato AB's PB Ratio of today is 2.25.
Good Sign:
Nolato AB stock PB Ratio (=2.36) is close to 2-year low of 2.21.
The historical rank and industry rank for Nolato AB's PB Ratio or its related term are showing as below:
CHIX:NOLABs'
s PB Ratio Range Over the Past 10 Years
Min: 2.06 Med: 3.92 Max: 9.28
Current: 2.36
During the past 13 years, Nolato AB's highest PB Ratio was 9.28. The lowest was 2.06. And the median was 3.92.
CHIX:NOLABs's PB Ratio is ranked worse than 52.8% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs CHIX:NOLABs: 2.36
During the past 12 months, Nolato AB's average Book Value Per Share Growth Rate was 5.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 0.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.40% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 14.10% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Nolato AB was 21.60% per year. The lowest was -0.80% per year. And the median was 11.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Nolato AB PB Ratio Related Terms
Nolato AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Nolato AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Nolato AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nolato AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nolato AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Nolato AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Nolato AB's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Nolato AB (CHIX:NOLABS) has a PB Ratio of 2.25 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nolato AB and its competitors. This is 43% below median its historical median of 3.92. Over the past decade, Nolato AB's PB Ratio has ranged from 2.06 to 9.28. According to the industry distribution chart, Nolato AB ranks #415 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 52.8%.
Is Nolato AB's PB Ratio too high?
Nolato AB's current PB Ratio of 2.25 is 43% below median its 10-year median of 3.92. Over the past 10 years, this metric has ranged from a low of 2.06 to a high of 9.28. The Medical Devices & Instruments industry median PB Ratio is 2.06. Nolato AB's value of 2.25 is 9.2% above this industry median. Based on the distribution chart, Nolato AB ranks #415 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Nolato AB has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nolato AB's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nolato AB ranks #415 out of 786 companies for PB Ratio. This places Nolato AB in the lower half of its industry. The industry median PB Ratio is 2.06. Nolato AB's value of 2.25 is 9.2% above this benchmark. Historically, Nolato AB's own PB Ratio has ranged from 2.06 to 9.28 over the past decade. While the company's 10-year median is 3.92 vs. the industry median of 2.06, Nolato AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.06, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nolato AB's current PB Ratio of 2.25 is 9.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Nolato AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nolato AB's current PB Ratio is 2.25, which is 43% below median its own 10-year median of 3.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nolato AB stock overvalued right now?
Based on GuruFocus' analysis, Nolato AB (CHIX:NOLABS) is currently considered Modestly Undervalued. The stock's GF Value™ is kr58.57, compared to a current price of kr48.88 — trading 16.6% below its estimated fair value. The current PB Ratio is 2.25, which is 43% below median its 10-year median of 3.92 and 9.2% above the Medical Devices & Instruments industry median of 2.06. Nolato AB's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Nolato AB (CHIX:NOLABS), the current PB Ratio is 2.25 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nolato AB (CHIX:NOLABS) Overvalued in 2026?
Based on GuruFocus' analysis, Nolato AB stock appears to be undervalued.
The current stock price of kr48.88 is trading 16.6% below its estimated GF Value™ of kr58.57.
GuruFocus considers Nolato AB to be Modestly Undervalued.
Key valuation signals for CHIX:NOLABS:
PB Ratio: 2.25 (43% below median its 10-year median of 3.92)
GF Value™: kr58.57 vs. price of kr48.88 (16.6% below fair value)
Industry Position: 9.2% above the Medical Devices & Instruments median (#415 of 786)
No single metric tells the full story. See the CHIX:NOLABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nolato AB is a Swedish company that develops and manufactures plastic, silicone, and thermoplastic elastomer products. The firm's operations are organized into two segments: Medical Solutions and Engineered Solutions. The company generates the majority of its revenue from the Medical Solutions segment, which is engaged in the development and manufacture of complex product systems and components for medical devices, the pharmaceutical industry, and diagnostics. The Engineered Solutions design, development, industrialization, and manufacture of subsystems and ready-packaged products for a range of industries, including offerings within EMC and thermal solutions. Geographically, the firm generates key revenue from the Rest of Europe and the United States.
78GF Score
Get the complete analysis for CHIX:NOLABS
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:NOLABS has been successfully added to your 
